Related Experiment Video
Updated: Jul 12, 2026

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
A live attenuated West Nile virus strain as a potential veterinary vaccine
S Lustig1, U Olshevsky, D Ben-Nathan
1Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona. lustig@iibr.gov.il
Abstract:
This article reviews the development of two attenuated West Nile virus (WNV) variants, WNI-25 and WNI-25A. These variants have lost the neuroinvasion trait of the parental virus. Attenuation was achieved through serial passages in mosquito cells and neutralization escape from WNV-specific monoclonal antibody. Genetic analysis reveals amino acid changes between the parental and each of the variants. The attenuated variants preserve the ability to replicate in mice and geese and to induce a protective immune response. WNI-25A was found to be a genetically stable virus. This variant was successfully used as a live vaccine to protect geese against a wild-type virulent WNV field isolate that closely resembles the WNV isolated during the 1999 New York epidemic.
Related Concept Videos
Rabies
Arboviral Encephalitis

